Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

Author: Lisa Levin | November 14, 2022 02:05pm

Gainers

  • Freight Technologies, Inc. (NASDAQ:FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
  • Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) shares jumped 114.9% to $20.20. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share.
  • ToughBuilt Industries, Inc. (NASDAQ:TBLT) shares climbed 28.6% to $2.83 after the company reported better-than-expected Q3 EPS results.
  • Cosmos Holdings Inc. (NASDAQ:COSM) rose 27.7% to $0.1569 after gaining 7% on Friday.
  • Yiren Digital Ltd. (NYSE:YRD) jumped 27.7% to $1.29.
  • Exela Technologies, Inc. (NASDAQ:XELA) gained 25.8% to $0.35.
  • Ardelyx, Inc. (NASDAQ:ARDX) surged 25.6% to $1.5700. The FDA published briefing documents on Ardelyx's kidney disease treatment.
  • Ensysce Biosciences, Inc. (NASDAQ:ENSC) jumped 23% to $2.3700 after the company announced it received written guidance from the FDA that an acute pain indication may be appropriate for its lead Trypsin Activated Abuse Protection product, PF614.
  • CIRCOR International, Inc. (NYSE:CIR) surged 20.6% to $26.15 following better-than-expected quarterly results.
  • HireRight Holdings Corporation (NYSE:HRT) gained 19.1% to $9.18. HireRight’s board authorized a $100 million share repurchase program.
  • PDS Biotechnology Corporation (NASDAQ:PDSB) jumped 18.2% to $6.62 after the company announced 100% clinical response in cervical cancer patients in preliminary data from the IMMUNOCERV Phase 2 clinical trial. The company also reported better-than-expected Q3 EPS results.
  • Daseke, Inc. (NASDAQ:DSKE) gained 15.7% to $6.91. Daseke said that the company has entered into an agreement with its Founder, Mr. Don R. Daseke, and his affiliates, to repurchase their total holdings in the company at a purchase price of $6 per share.
  • HUTCHMED (China) Limited (NASDAQ:HCM) rose 15.3% to $11.41 after the company reported positive topline result in Fruquintinib Phase III FRUTIGA study in second-line gastric cancer in China.
  • Armata Pharmaceuticals, Inc. (NYSE:ARMP) jumped 14.6% to $3.29. Armata Pharmaceuticals recently reported a Q3 loss of $0.24 per share.
  • MINISO Group Holding Limited (NYSE:MNSO) gained 14.5% to $8.10 after the company reported better-than-expected Q1 financial results.
  • Helius Medical Technologies, Inc. (NASDAQ:HSDT) gained 14% to $0.2975 following strong quarterly results.
  • Agenus Inc. (NASDAQ:AGEN) rose 13.8% to $2.8550. Agenus recently posted a Q3 loss of $0.19 per share.
  • HUTCHMED (China) Limited (NASDAQ:HCM) surged 13.1% to $11.20 after the company reported initial results from FRUTIGA. The company said the trial met one of the primary endpoints of statistically significant improvement in progression-free survival.
  • Xinyuan Real Estate Co., Ltd. (NYSE:XIN) surged 12.6% to $0.5181.
  • Babcock & Wilcox Enterprises, Inc. (NYSE:BW) gained 10.4% to $5.38. Babcock & Wilcox Construction Co. LLC was awarded $42 million in large North American upgrade projects.
  • Secoo Holding Limited (NASDAQ:SECO) gained 10.3% to $0.32.
  • TAL Education Group (NYSE:TAL) gained 10.1% to $5.24.
  • Kidpik Corp. (NASDAQ:PIK) rose 10.1% to $0.9798. KIDPIK is expected to release Q3 results on November 15, 2022.
  • monday.com Ltd. (NASDAQ:MNDY) surged 9.2% to $103.94 after the company reported better-than-expected Q3 financial results.
  • Cabaletta Bio, Inc. (NASDAQ:CABA) gained 8.8% to $2.59. Cabaletta Bio recently posted a Q3 loss of $0.39 per share.

Lufax Holding Ltd (NYSE:LU) jumped 6.8% to $1.9550.

 


Losers

  • Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) shares dipped 83.3% to $0.6781 after the company reported topline results from the STS101 SUMMIT Phase 3 efficacy trial in migraine patients.
  • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) dipped 39.8% to $2.74 after the company reported Q3 earnings results and provided a business update.
  • POINT Biopharma Global Inc. (NASDAQ:PNT) dropped 33% to $6.12. Lantheus and POINT Biopharma announced collaboration and exclusive license agreements for commercialization of PNT2002 & PNT2003.
  • Nuwellis, Inc. (NASDAQ:NUWE) fell 31.7% to $0.1366. Nuwellis recently reported worse-than-expected Q3 EPS and sales results.
  • MorphoSys AG (NASDAQ:MOR) shares fell 28.8% to $3.91. MorphoSys’ licensing partner Roche issued an update on Phase 3 GRADUATE program for Gantenerumab in early Alzheimer’s disease.
  • Stoke Therapeutics, Inc. (NASDAQ:STOK) dipped 26% to $9.24 after the company reported a wider Q3 loss.
  • Actelis Networks, Inc. (NASDAQ:ASNS) dropped 21.5% to $0.62. Actelis Networks posted a Q3 loss of $0.13 per share.
  • Tremor International Ltd (NASDAQ:TRMR) fell 21.2% to $6.95 after gaining over 5% on Friday.
  • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) dipped 21% to $0.9401. Infinity Pharmaceuticals posted a Q3 loss of $0.12 per share and issued an update from MARIO-3 study.
  • 908 Devices Inc. (NASDAQ:MASS) declined 19.2% to $12.93 as the company lowered its FY22 revenue forecast.
  • Oatly Group AB (NASDAQ:OTLY) fell 18.2% to $2.0050 after the company reported worse-than-expected Q3 EPS and sales results.
  • Fast Radius, Inc. (NASDAQ:FSRD) shares fell 17.2% to $0.2015 after dropping around 7% on Friday.
  • Lumos Pharma, Inc. (NASDAQ:LUMO) declined 16.5% to $7.44. Lumos Pharma posted a Q3 loss of $0.86 per share and disclosed interim results from two Phase 2 trials evaluating oral LUM-201 for moderate pediatric growth hormone deficiency.
  • TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) dropped 16.4% to $0.6001. TOMI Environmental Solutions recently posted a Q3 loss of $0.03 per share.
  • Altus Power, Inc. (NYSE:AMPS) dropped 15.2% to $7.24 following Q3 results.
  • Minerva Surgical, Inc. (NASDAQ:UTRS) declined 15.4% to $0.2404.
  • CareMax, Inc. (NASDAQ:CMAX) dipped 14.8% to $4.64. CareMax recently posted a Q3 loss of $0.25 per share.
  • Performance Shipping Inc. (NASDAQ:PSHG) fell 14.4% to $0.2695. Performance Shipping posted Q3 EPS of $0.10.
  • Ascendis Pharma A/S (NASDAQ:ASND) dipped 13.3% to $114.48. Ascendis Pharma announced positive topline results from the ACcomplisH Phase 2 trial of once-weekly TransCon CNP compared to a placebo in children with achondroplasia aged 2 to 10 years old.
  • Algonquin Power & Utilities Corp. (NYSE:AQN) fell 12% to $8.18. Algonquin Power & Utilities Corp reported worse-than-expected Q3 EPS. Several analysts downgraded the stock today.
  • Transphorm, Inc. (NASDAQ:TGAN) fell 11.7% to $6.22.
  • 5E Advanced Materials Inc. (NASDAQ:FEAM) dropped 9.9% to $11.32. 5E Advanced Materials, on Friday, reported Q1 results.
  • CS Disco, Inc. (NYSE:LAW) fell 9.6% to $9.35.
  • Kura Sushi USA, Inc. (NASDAQ:KRUS) fell 9.4% to $59.64. Kura Sushi USA recently reported Q4 financial results.
  • 8x8, Inc. (NYSE:EGHT) fell 9.4% to $4.3050.
  • Qurate Retail, Inc. (NASDAQ:QRTEA) dropped 9.1% to $1.7450.
  • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 8.9% to $3.5977. Bed Bath & Beyond reported additional privately negotiated senior notes exchanges and concurrent private placement of common stock with several institutional holders.

Posted In: AGEN AMPS AQN ARDX ARMP ASND ASNS BBBY BW CABA CIR CMAX COSM DSKE EGHT ENSC FEAM FRGT FSRD HCM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist